Pharma IQ | 06/14/2010
Ensuring eCTD readiness is now critical for gaining first time market approval. Dr. Klaus Menges from the Division of Strategy and Planning, at the Federal Institute for Drugs and Medical Devices, Bfarm joins Pharma IQ to discuss strategies for successful eCTD lifecycle management.
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More